Adam Schayowitz, EVP, Head of R&D at Zymeworks Inc. (ZYME), sold 13,832 shares at $25.85 ($358K) on 2026-10-09, disclosed to the SEC on 2026-10-09.
Open-market sale of $358k ZYME by EVP, Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.